Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC

Thomas A. Hensing, Xiaofei Wang, Thomas E. Stinchcombe, Junheng Gao, Michael V. Knopp, Mark Watson, Arkadiusz Z. Dudek, Stephen L. Graziano, Jyoti D. Patel, Bryan A. Faller, Konstantin H. Dragnev, David Kozono, Everett E. Vokes

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC'. Together they form a unique fingerprint.

Medicine & Life Sciences